# Restoration of Cutaneous Sensorum in Patients With Diabetic Peripheral Neuropathy (DPN) Via Metanx®

> **NCT00933998** · NA · COMPLETED · sponsor: **Carolina Musculoskeletal Institute** · enrollment: 20 (actual)

## Conditions studied

- Diabetic Peripheral Neuropathy

## Interventions

- **OTHER:** Metanx® (Oral L-methylfolate, Methylcobalamin and Pyridoxal 5'-phosphate)

## Key facts

- **NCT ID:** NCT00933998
- **Lead sponsor:** Carolina Musculoskeletal Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2008-10
- **Final completion:** —
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2014-01-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00933998

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00933998, "Restoration of Cutaneous Sensorum in Patients With Diabetic Peripheral Neuropathy (DPN) Via Metanx®". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00933998. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*